Objective: Alterations in glucose and lipid metabolism, lactic acidemia, bone disorders, and
abnormal body fat distribution have been recognized recently as frequent complications …

Over the past 10 years, in conjunction with the broad availability of potent antiretroviral
regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted …

Abstract Changes in fat distribution, dyslipidemia, disordered glucose metabolism, and lactic
acidosis have emerged as significant challenges to the treatment of human …

AIDS: Reports of metabolic disorders, such as diabetes mellitus and hyperlipidemia,
occurring during treatment with protease inhibitor (PI) regimens are prompting patients and …

The treatment of metabolic disease is becoming an increasingly important component of the
long-term management of patients with well controlled HIV on antiretroviral therapy (ART) …

HIV infection and antiretroviral therapy (ART) use are associated with perturbations in
glucose and lipid metabolism. Increasing incidence of diabetes, cardiovascular disease, and …

Nutritional alterations are common in HIV infection. Early studies documented weight loss
and protein depletion, a finding associated with body cell mass depletion in untreated …

Background: Metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular
disease and diabetes, many of which are associated with HIV and antiretroviral therapy …

Background Metabolic diseases are frequently observed in HIV‐infected persons and, as
the risk of contracting these diseases is age‐related, their prevalence will increase in the …

The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …